SMAD3 and cardiac hypertrophy: The expression of TGF-β and p-Smad3 reduced after QYYY treatment, as well as MYH7 and MYH7/MYH6, which demonstrated QYYY granules can downregulate the key genes involved in cardiac fibrosis and cardiac hypertrophy.